Publications by authors named "Laura Cons"

Claim this Profile
T
Tumor-dependent myeloid and lymphoid cell recruitment in genO-BRGSF-HIS mice: a novel tool for evaluating immunotherapies.
Gaëlle H Martin, Siham Hedir, Florent Creusat, Alexis Gonon, Amélie Marguier, Laura Cons

Front Immunol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and characterization of NILK-2301, a novel CEACAM5xCD3 κλ bispecific antibody for immunotherapy of CEACAM5-expressing cancers.
Anja Seckinger, Sara Majocchi, Valéry Moine, Lise Nouveau, Hoang Ngoc, Laura Cons

J Hematol Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD47xCD19 bispecific antibody triggers recruitment and activation of innate immune effector cells in a B-cell lymphoma xenograft model.
Xavier Chauchet, Laura Cons, Laurence Chatel, Bruno Daubeuf, Gérard Didelot

Exp Hematol Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunological analysis of the murine anti-CD3-induced cytokine release syndrome model and therapeutic efficacy of anti-cytokine antibodies.
Lise Nouveau, Vanessa Buatois, Laura Cons, Laurence Chatel, Guillemette Pontini

Eur J Immunol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Development of a Bispecific Antibody that Safely and Effectively Targets CD19 and CD47 for the Treatment of B-Cell Lymphoma and Leukemia.
Vanessa Buatois, Zoë Johnson, Susana Salgado-Pires, Anne Papaioannou, Eric Hatterer, Laura Cons

Mol Cancer Ther· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of a mouse model to identify a blood biomarker for IFNγ activity in pediatric secondary hemophagocytic lymphohistiocytosis.
Vanessa Buatois, Laurence Chatel, Laura Cons, Sabrina Lory, Françoise Richard

Transl Res· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective Blockade of the Ubiquitous Checkpoint Receptor CD47 Is Enabled by Dual-Targeting Bispecific Antibodies.
Elie Dheilly, Valéry Moine, Lucile Broyer, Susana Salgado-Pires, Zoë Johnson, Laura Cons

Mol Ther· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploiting light chains for the scalable generation and platform purification of native human bispecific IgG.
Nicolas Fischer, Greg Elson, Giovanni Magistrelli, Elie Dheilly, Nicolas Fouque, Laura Cons

Nat Commun· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GlycoDelete engineering of mammalian cells simplifies N-glycosylation of recombinant proteins.
Leander Meuris, Francis Santens, Greg Elson, Nele Festjens, Morgane Boone, Laura Cons

Nat Biotechnol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-CD79 antibody induces B cell anergy that protects against autoimmunity.
Ian R Hardy, Nadia Anceriz, François Rousseau, Matt B Seefeldt, Eric Hatterer, Laura Cons

J Immunol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of a surrogate murine antibody to model anti-human CD3 therapies.
Fabien Dépis, Eric Hatterer, Romain Ballet, Bruno Daubeuf, Laura Cons

MAbs· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis